Gusakovs v. Johnson & Johnson

District Court, D. Massachusetts·Decided December 5, 2023·No. 1:17-cv-11502·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

ALEKSEJ GUSAKOVS,

Plaintiff,

v. CIVIL ACTION NO. 1:17-11502-DJC

JOHNSON & JOHNSON and DEPUY SYNTHES SALES, INC.,

Defendants.

MEMORANDUM AND ORDER ON NON-PARTY MATTHEW SCHMIT’S MOTION FOR PROTECTIVE ORDER (#142)

KELLEY, U.S.M.J. This case involves allegations that defendants Johnson & Johnson (“J&J”) and DePuy Synthes Sales, Inc. (“DePuy”) wrongfully terminated plaintiff Aleksej Gusakovs in violation of the retaliation provisions in the federal False Claims Act (“FCA”), 31 U.S.C. § 3730(h), and the Massachusetts False Claims Act (“MFCA”), Mass. Gen. Laws, Ch. 12 § 5j, as well as other state common law. (#107 (2d Am. Compl., hereinafter “SAC”) at 22-27.) Pending before the court is non-party Matthew Schmit’s motion for a protective order to limit the scope of his deposition scheduled for December 13, 2023. (#142.) Plaintiff opposed (#151), and defendants did not weigh in. The court heard argument on December 4, 2023 and DENIED Mr. Schmit’s motion for the following reasons. (#153.) I. Background. The court assumes familiarity with the factual and procedural background set out in the district court’s June 16, 2023 memorandum and order (the “June 16 Order”) (#105 at 3-10), and will only set out the facts and allegations relevant to the issues here. Plaintiff alleges that in 2015-2016 he witnessed wrongdoing by defendants’ employees,

including alleged kickbacks to a surgeon at Boston Medical Center (“BMC”) and instances in which defendants’ employees, including plaintiff’s supervisor, Matthew Capobianco, provided non-sterilized equipment to doctors. See #107 ¶¶ 18-30. On October 29, 2016, plaintiff claims he reported the misconduct to J&J’s Corporate Internal Audit Department. Id. ¶ 31. Seven months later, plaintiff claims he reported the misconduct to the government, and in May 2017, he was interviewed at the U.S. Attorney’s Office (“USAO”) in Boston. Id. ¶ 36. Also in May 2017, the Federal Bureau of Investigations (“FBI”) interviewed Mr. Capobianco, and he allegedly informed plaintiff of the interview afterwards. Id. ¶ 39. In June 2017, the Boston USAO issued a subpoena to J&J relating to the alleged misconduct. Id. ¶ 41. Also in May 2017, after another alleged

sterilization-related incident involving Mr. Capobianco, plaintiff reported directly to BMC. Id. ¶ 37. Mr. Capobianco was immediately banned from the hospital, and BMC demanded additional information from plaintiff regarding the alleged misconduct. Id. ¶ 38. Around the same time, plaintiff began to feel overwhelmed at work. He claims he requested additional support from his superiors and sales colleagues, but “those requests essentially were ignored.” Id. ¶ 43. Mr. Capobianco also began to allegedly threaten and harass plaintiff by, for instance, asking about plaintiff’s family “an odd manner that Plaintiff interpreted as being threatening,” and visiting him at BMC even though he had been banned. Id. ¶ 48. In June 2017, plaintiff took a short-term disability leave for a disability related to stress, which was extended through December 26, 2017. Id. ¶¶ 45-46. While on leave, defendants demanded the return of his work phone and iPad for inspection related to the investigation into the alleged wrongdoing. Id. ¶ 51. Then, in January 2018, plaintiff began to receive correspondence from defendants indicating that he had been terminated. Id. ¶¶ 52-58. In August 2017, while on leave, plaintiff initiated this lawsuit as a John Doe relator on

behalf of the government, raising claims against defendants and DePuy Synthes, Inc. under the FCA and Anti-Kickback statue (“AKS”) relating to alleged unlawful billing practices and kickbacks. (#2 (Compl.).) Then in March 2018, after he began to receive correspondence indicating that he had been terminated, plaintiff amended his complaint to assert additional claims for, inter alia, FCA retaliation, MFCA retaliation, and wrongful termination in violation of public policy under Massachusetts common law. (#13 (1st Am. Compl., hereinafter “FAC”).) In September 2022, the government intervened against DePuy and DePuy Sales, Inc., as to plaintiff’s FCA claims against them related to illegal kickbacks; the government declined to intervene with respect to plaintiff’s other claims and declined to intervene against J&J. (#62 at 1.)

In January 2023, plaintiff, defendants, DePuy Synthes, Inc., and the government signed a settlement agreement (#70), and then plaintiff and the government moved to dismiss all claims in the FAC unrelated to plaintiff’s employment claims. (#72.) The court dismissed those claims later that month. (#73.) Plaintiff then moved for leave to file the SAC, dropping DePuy Synthes, Inc. from the lawsuit and adding allegations related to his employment claims. (#91.) Defendants opposed the motion for leave to file, moved to dismiss the FAC and SAC, and further moved to strike allegations related to, inter alia, the alleged kickbacks in the SAC. (##96, 99.) In the June 16 Order, the district court allowed plaintiff’s motion for leave to file the SAC, allowed defendants’ motion to dismiss in part as to all claims except plaintiff’s FCA/MFCA retaliation and wrongful termination claims, and denied defendants’ request to strike plaintiff’s allegations related to the alleged kickbacks.1 (#105.) II. Matthew Schmit’s Motion for Protective Order (#142). On November 24, 2023, Mr. Schmit filed this motion for protective order under Federal

Rules of Civil Procedure 26(c) and 45(d)(3) seeking to prohibit plaintiff from examining Mr. Schmit on facts related to the dismissed and settled claims at his deposition scheduled for December 13, 2023. (#142); see #143 at 4. He seeks to limit the scope of his upcoming deposition to the following two lines of inquiry: (1) whether Mr. Schmit was aware that plaintiff engaged in protected activity; and (2) whether plaintiff was terminated as a result of that protected activity. (#143 at 4.) In particular, he seeks to prohibit plaintiff from questioning him on facts related to the alleged kickbacks and sterilization issues that plaintiff claims to have reported and that formed the basis for the FCA and MFCA claims that have been settled and dismissed. Id. Mr. Schmit argues that whether such misconduct actually occurred is not relevant to plaintiff’s remaining

employment claims under Fed. R. Civ. P. 26(b)(1), and that such questioning would be unduly burdensome as he would need to spend hours preparing in order to respond to the irrelevant questions. Plaintiff opposes and argues that first, as plaintiff’s “immediate supervisor,” Mr. Schmit likely has knowledge of many additional categories of information that would be directly relevant to plaintiff’s employment claims and that were not enumerated in Mr. Schmit’s motion, such as “what [Mr. Schmit] knows about Plaintiff’s reputation and performance as an employee of

1 Defendants also moved to strike allegations related to the death of a former regional sales manager. See #100 at 25-26. District Judge Casper allowed defendants’ motion as to those allegations. (#105 at 29-30.) Those allegations have no bearing here. Defendants, especially given the fact that Mr. Schmit signed off on numerous year-end reviews concerning Plaintiff’s work,” and “whether Plaintiff was, in fact, terminated.” (#151 at 1-4.) Second, plaintiff argues that Judge Casper already ruled that allegations related to the alleged kickbacks are relevant to plaintiff’s remaining FCA/MFCA retaliation claims, see #105 at 29. (#151 at 5.) And third, he asserts that Mr. Schmit has not sufficiently shown that such questioning

Free access — add to your briefcase to read the full text and ask questions with AI

Gusakovs v. Johnson & Johnson, (D. Mass. 2023).

Gusakovs v. Johnson & Johnson (Gusakovs v. Johnson & Johnson) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)
Sheppard v. 265 Essex St. Operating Co.
299 F. Supp. 3d 278 (District of Columbia, 2018)